Comparison Study of Surgical Staplers for the Treatment of Hemorrhoids (HEMOSTASIS)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01306877|
Recruitment Status : Completed
First Posted : March 2, 2011
Results First Posted : October 29, 2014
Last Update Posted : October 29, 2014
|Condition or disease||Intervention/treatment||Phase|
|Hemorrhoids||Device: EEA Hemorrhoid and Prolapse Stapling Set Device: Endosurgery Proximate PPH03 Stapling Set||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||149 participants|
|Intervention Model:||Parallel Assignment|
|Official Title:||Prospective Single Blinded Randomized Controlled Trial Comparing The Covidien EEA™ Hemorrhoid and Prolapse Stapling Set With DST Series™ Technology Vs. Ethicon PPH03 In A Hemorrhoidopexy Procedure (HEMOSTASIS)|
|Study Start Date :||January 2011|
|Actual Primary Completion Date :||August 2012|
|Actual Study Completion Date :||January 2013|
|Experimental: EEA Hemorrhoid and Prolapse Stapling Set||
Device: EEA Hemorrhoid and Prolapse Stapling Set
|Active Comparator: Endosurgery Proximate PPH03 Stapling Set||
Device: Endosurgery Proximate PPH03 Stapling Set
- Intraoperative Bleeding [ Time Frame: Day 0 - time of surgery ]Number of subjects who require intervention to stop intraoperative bleeding The analysis is based on the per protocol analysis set. Subjects who were misrandomized for excluded from this analysis therefore, the population here will differ from the participant flow.
- Post Operative Pain - (PI-NIRS) [ Time Frame: Day 0 minus 60 (baseline), Day 0 (discharge), Day 0 plus 7, Day 0 plus 30, Day 0 plus 90, Day 0 plus 180 ]
Post-operative pain as change from baseline pain score as measured by an 11-point Pain Intensity Numeric Rating Scale (PI-NRS). The range of the scale is 0-10 with 0 representing no pain and 10 representing the worst possible pain.
The data represented is the change in baseline score at the different timepoints.
- Post-Operative Pain (Analgesic Intake) [ Time Frame: Day 0, 1 week, 2 week, 1 month, 3 month, 6 month ]post operative pain measured in pos-surgical consumption of strong opioids by the number of participants in the study. Participants are included if they consumed analgesics or strong opiod at anytime during the study.
- Overall Quality of Life - General Health Score [ Time Frame: Day 0 minus 60, 1 week, 1 month, 3 months, 6 months ]Quality of life was measured by SF-12 questionnaire in change from baseline; the socring range is 0 - 100 with 0 = poor overall health and 100 = excellent overall health
- Location of the Staple Line [ Time Frame: Day 0 ]Distance of staple line to dentate line as measure by surgical ruler
- Length of Stay [ Time Frame: Day 0 time of discharge minus time of admission ]Length of hospital stay is defined as time of anoscope insertion until discharge
- Operative Room (OR) Time [ Time Frame: Day 0 ]Time of insertion of anoscope to time of anoscope removal after stapleline evaluation
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01306877
|United States, Florida|
|USF Tampa General Hospital Dept of Surgery|
|Tampa, Florida, United States, 33606|
|Principal Investigator:||Jorge Marcet, MD||University of South Florida|